Patrick Soon-Shiong emphasizes importance of lymphocytes at ASCO25
@DrPatSoonShiong: Soon-Shiong on lymphocytes at ASCO25
Cancer researcher and biotech entrepreneur Patrick Soon-Shiong highlights a pivotal observation about lymphocyte count at this year's ASCO25 conference.
In a recent revelation, Soon-Shiong, who has long advocated for the critical role of lymphocytes in cancer treatment, cited findings showing that ''every 10 percent decrease in ALC from baseline was associated with a 48 percent increase risk of death.'' This statement underscores the significance of maintaining lymphocyte levels in cancer patients.
He further mentioned the concept of the ''Cancer Bioshield,'' which he claims offers protection to patients. Soon-Shiong is eager to present these findings to the U.S. Food and Drug Administration later this month, which could potentially influence future cancer treatment protocols.
Loading...
Soon-Shiong's emphasis on lymphocyte dynamics and immune protection aligns with discussions at the Saudi-U.S. Investment Forum 2025, where advancements such as the bioshield were brought to the forefront. These themes further expand on his vision for a cancer paradigm shift, as highlighted during his recent address at the Riyadh forum.
